Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Adenocarcinoma of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04907643
What this trial is testing

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Who this might be right for
Cancer PainVisceral PainGastrointestinal Neoplasms+76 more
Cedars-Sinai Medical Center 360
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Study completedNCT00004910
What this trial is testing

Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction

Who this might be right for
Colorectal CancerConstipation, Impaction, and Bowel ObstructionExtrahepatic Bile Duct Cancer+6 more
Northwestern University
Early research (Phase 1)Ended earlyNCT02132403
What this trial is testing

(PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Illinois at Chicago 3
Testing effectiveness (Phase 2)Study completedNCT01064622
What this trial is testing

Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage IV Pancreatic Cancer AJCC v6 and v7
National Cancer Institute (NCI) 118
Testing effectiveness (Phase 2)Study completedNCT00003951
What this trial is testing

DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Daiichi Sankyo 37
Testing effectiveness (Phase 2)Looking for participantsNCT03175224
What this trial is testing

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced CancerRenal Cancer+15 more
Apollomics Inc. 497
Not applicableStudy completedNCT00369460
What this trial is testing

Changes in Muscle Tissue in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Case Comprehensive Cancer Center 9
Early research (Phase 1)Active Not RecruitingNCT02495896
What this trial is testing

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Pancreatic AdenocarcinomaNon-Resectable Cholangiocarcinoma+13 more
University of Southern California 61
Not applicableStudy completedNCT00900016
What this trial is testing

Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery

Who this might be right for
Pancreatic Cancer
Fox Chase Cancer Center 37
Not applicableEnrolling By InvitationNCT07241676
What this trial is testing

Early Recurrence After Surgery for Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Recurrent Pancreatic Adenocarcinoma
Azienda Ospedaliera di Padova 500
Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01924260
What this trial is testing

Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+3 more
Edward Kim 26
Early research (Phase 1)Study completedNCT00266097
What this trial is testing

Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerPancreatic Cancer
UNC Lineberger Comprehensive Cancer Center 23
Not applicableStudy completedNCT04596865
What this trial is testing

Recurrence After Whipple's (RAW) Study

Who this might be right for
Pancreatic CancerAmpullary CancerBile Duct Cancer+11 more
University Hospital Plymouth NHS Trust 1,484
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Not applicableStudy completedNCT04400357
What this trial is testing

Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors

Who this might be right for
Pancreatic AdenocarcinomaPancreatic CystsPancreatic Endocrine Tumors+4 more
Ruijin Hospital 268
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Study completedNCT00923299
What this trial is testing

Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With Gemcitabine

Who this might be right for
Pancreatic Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 33
Testing effectiveness (Phase 2)Study completedNCT00260364
What this trial is testing

Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Royal Marsden NHS Foundation Trust 44
Next Page